• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Pain (1994)
Event Type  Injury  
Event Description
This spontaneous case was reported by a healthcare professional and describes the occurrence of pelvic pain ("intermittent pelvic pain, especially when seated") in a 59 year-old female patient who had essure inserted.Additional non-serious events are detailed below.As concurrent condition the report mentioned endometriosis.On (b)(6) 2009, the patient had essure inserted.On unknown date she experienced pelvic pain (seriousness criterion intervention required) and arthralgia ("joint pain").The patient was treated with surgery (laparoscopy and.Extended total hysterectomy on (b)(6) 2024).Essure was removed on (b)(6) 2024.No causality assessment was received for essure with regard to pelvic pain or arthralgia.The reporter commented: adnexectomy via laparoscopy in 2013.Esssure removal at patient's request: on (b)(6) 2024 laparoscopy and extended hysterectomy.Diagnostic results (normal ranges are provided in parenthesis if available): body mass index: 22.491 kg/sqm.Based on the available information, a review of our complaint records and other relevant data will be conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This spontaneous case was reported by a healthcare professional and describes the occurrence of pelvic pain ("intermittent pelvic pain, especially when seated") in a 59 year-old female patient who had essure inserted.Additional non-serious events are detailed below.As concurrent condition the report mentioned endometriosis.On (b)(6) 2009, the patient had essure inserted.Essure was removed on (b)(6) 2024.On unknown date she experienced pelvic pain (seriousness criterion intervention required) and arthralgia ("joint pain").The patient was treated with surgery (laparoscopy and.Extended total hysterectomy on (b)(6) 2024).No causality assessment was received for essure with regard to pelvic pain or arthralgia.The reporter commented: adnexectomy via laparoscopy in 2013.Esssure removal at patient's request: on (b)(6) 2024 laparoscopy and extended hysterectomy.Diagnostic results (normal ranges are provided in parenthesis if available): body mass index: 22.491 kg/sqm.Quality-safety evaluation of ptc: for essure: no defect could be confirmed by the manufacturer.All product batches have met the specifications regarding labeling, material, and process controls at time of release.Trend analyses of complaints are reviewed regularly, no signal was observed with regard to the reported complaint reason.The risk management file was reviewed and an update was not deemed required.A technical investigation of the complaint sample and batch record review could not be conducted, as no sample or batch number were available.The most recent follow-up information incorporated above includes data received on: 21-feb-2024: quality safety evaluation of ptc.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
janice miller
100 bayer blvd.
p.o. box 915
whippany, NJ 07981
MDR Report Key18742781
MDR Text Key335786403
Report Number2951250-2024-00140
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Is the Reporter a Health Professional? No
Date Manufacturer Received02/21/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexFemale
Patient Weight65 KG
-
-